"When a child is seriously sick or injured, an entire lifetime hangs in the balance. Yet, nationally, funding for pediatric research continues to trail efforts targeted for adults. Children deserve innovation inspired by their needs. That’s why Children’s National Hospital is creating a one-of-a-kind pediatric research and innovation hub. Located on a nearly 12-acre portion of the former Walter Reed Army Medical Center campus, we will combine our strengths with those of public and private partners who share our vision. Here, breakthrough discoveries can more quickly be translated into new treatments and technologies benefitting kids."

During the past decade, Children's Research Institute conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Research Institute" #1 sponsor was "Children's National Research Institute" with 10 trials, followed by "John van den Anker" with 2 trials sponsored, "Supernus Pharmaceuticals, Inc." with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored and "Ascentage Pharma Group Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Research Institute" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Children's Hospital of Philadelphia" with 2 trials as a collaborator, "Children's National Research Institute" with 2 trials as a collaborator, "Georgetown University" with 2 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Children's Research Institute" are "Attention Deficit Hyperactivity Disorder" (2 trials), "HIV Infections" (2 trials), "Melanoma" (2 trials), "Urea Cycle Disorders" (2 trials) and "ADD" (1 trials). Many other conditions were trialed in "Children's Research Institute" in a lesser frequency.

Most popular intervention types in "Children's Research Institute" are "Drug" (14 trials), "Behavioral" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "SPN-810" (2 trials), "APG-115+Pembrolizumab" (1 trials), "Acetaminophen/APAP" (1 trials) and "Behavioral" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Research Institute" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Children's Research Institute". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Children's Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Research Institute, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".